231 related articles for article (PubMed ID: 30192930)
21. Long-Term Beta-Blocker Therapy after Myocardial Infarction in the Reperfusion Era: A Systematic Review.
Hong J; Barry AR
Pharmacotherapy; 2018 May; 38(5):546-554. PubMed ID: 29601115
[TBL] [Abstract][Full Text] [Related]
22. Early beta-blocker therapy improves in-hospital mortality of patients with non-ST-segment elevation myocardial infarction - a meta-analysis.
Mirna M; Berezin A; Schmutzler L; Demirel O; Hoppe UC; Lichtenauer M
Int J Cardiol; 2023 Oct; 389():131160. PubMed ID: 37423571
[TBL] [Abstract][Full Text] [Related]
23. Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database.
Paolillo S; Mapelli M; Bonomi A; Corrà U; Piepoli M; Veglia F; Salvioni E; Gentile P; Lagioia R; Metra M; Limongelli G; Sinagra G; Cattadori G; Scardovi AB; Carubelli V; Scrutino D; Badagliacca R; Raimondo R; Emdin M; Magrì D; Correale M; Parati G; Caravita S; Spadafora E; Re F; Cicoira M; Frigerio M; Bussotti M; Minà C; Oliva F; Battaia E; Belardinelli R; Mezzani A; Pastormerlo L; Di Lenarda A; Passino C; Sciomer S; Iorio A; Zambon E; Guazzi M; Pacileo G; Ricci R; Contini M; Apostolo A; Palermo P; Clemenza F; Marchese G; Binno S; Lombardi C; Passantino A; Perrone Filardi P; Agostoni P
Eur J Heart Fail; 2017 Jul; 19(7):904-914. PubMed ID: 28233458
[TBL] [Abstract][Full Text] [Related]
24. Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction.
Makam RC; Erskine N; McManus DD; Lessard D; Gore JM; Yarzebski J; Goldberg RJ
Am J Cardiol; 2016 Dec; 118(12):1792-1797. PubMed ID: 27743577
[TBL] [Abstract][Full Text] [Related]
25. The effect of ivabradine therapy on heart failure patients with reduced ejection fraction: a systematic review and meta-analysis.
Hartmann C; Bosch NL; de Aragão Miguita L; Tierie E; Zytinski L; Baena CP
Int J Clin Pharm; 2018 Dec; 40(6):1443-1453. PubMed ID: 30173307
[TBL] [Abstract][Full Text] [Related]
26. Prognostic impact of prepercutaneous coronary intervention TIMI flow in patients with ST-segment and non-ST-segment elevation myocardial infarction: Results from the FAST-MI 2010 registry.
Bailleul C; Aissaoui N; Cayla G; Dillinger JG; Jouve B; Schiele F; Ferrières J; Simon T; Danchin N; Puymirat E;
Arch Cardiovasc Dis; 2018 Feb; 111(2):101-108. PubMed ID: 28939193
[TBL] [Abstract][Full Text] [Related]
27. Favorable effects of intravenous beta blockers in ST elevation myocardial infarct: time for a revival?
Santucci A; Cavallini C
J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e26-e30. PubMed ID: 29538140
[No Abstract] [Full Text] [Related]
28. Meta-Analysis of Relation Between Oral β-Blocker Therapy and Outcomes in Patients With Acute Myocardial Infarction Who Underwent Percutaneous Coronary Intervention.
Huang BT; Huang FY; Zuo ZL; Liao YB; Heng Y; Wang PJ; Gui YY; Xia TL; Xin ZM; Liu W; Zhang C; Chen SJ; Pu XB; Chen M; Huang DJ
Am J Cardiol; 2015 Jun; 115(11):1529-38. PubMed ID: 25862157
[TBL] [Abstract][Full Text] [Related]
29. The association of left ventricular ejection fraction with clinical outcomes after myocardial infarction: Findings from the Acute Coronary Treatment and Intervention Outcomes Network (ACTION) Registry-Get With the Guidelines (GWTG) Medicare-linked database.
Sutton NR; Li S; Thomas L; Wang TY; de Lemos JA; Enriquez JR; Shah RU; Fonarow GC
Am Heart J; 2016 Aug; 178():65-73. PubMed ID: 27502853
[TBL] [Abstract][Full Text] [Related]
30. Effect of β-blocker Therapy on Hospital Readmission and Mortality in Heart Failure Patients With Concurrent Cocaine Use.
Egbuche O; Ekechukwu I; Effoe V; Maduabum N; Millard HR; Maihemuti A; Cross JA; Adedinsewo D; Onwuanyi AE
J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):518-523. PubMed ID: 29793347
[TBL] [Abstract][Full Text] [Related]
31. Association of beta-blocker therapy at discharge with clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Yang JH; Hahn JY; Song YB; Choi SH; Choi JH; Lee SH; Kim JH; Ahn YK; Jeong MH; Choi DJ; Park JS; Kim YJ; Park HS; Han KR; Rha SW; Gwon HC
JACC Cardiovasc Interv; 2014 Jun; 7(6):592-601. PubMed ID: 24947717
[TBL] [Abstract][Full Text] [Related]
32. Secondary prevention strategies after an acute ST-segment elevation myocardial infarction in the AMI code era: beyond myocardial mechanical reperfusion.
Ribas N; García-García C; Meroño O; Recasens L; Pérez-Fernández S; Bazán V; Salvatella N; Martí-Almor J; Bruguera J; Elosua R
BMC Cardiovasc Disord; 2017 Feb; 17(1):54. PubMed ID: 28173757
[TBL] [Abstract][Full Text] [Related]
33. Impact of cardiac rehabilitation referral on one-year outcome after discharge of patients with acute myocardial infarction.
Hermann M; Witassek F; Erne P; Rickli H; Radovanovic D
Eur J Prev Cardiol; 2019 Jan; 26(2):138-144. PubMed ID: 30335503
[TBL] [Abstract][Full Text] [Related]
34. Usefulness of universal beta-blocker therapy in patients after ST-elevation myocardial infarction.
Ferreira JA; Baptista RM; Monteiro SR; Gonçalves LM;
Medicine (Baltimore); 2021 Jan; 100(3):e23987. PubMed ID: 33545989
[TBL] [Abstract][Full Text] [Related]
35. Relationship Between β-Blocker Therapy at Discharge and Clinical Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
Li C; Sun Y; Shen X; Yu T; Li Q; Ruan G; Zhang L; Huang Q; Zhuang H; Huang J; Ni L; Wang L; Jiang J; Wang Y; Wang DW
J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27852588
[TBL] [Abstract][Full Text] [Related]
36. Long-term prescription of beta-blocker delays the progression of heart failure with preserved ejection fraction in patients with hypertension: A retrospective observational cohort study.
Gu J; Fan YQ; Bian L; Zhang HL; Xu ZJ; Zhang Y; Chen QZ; Yin ZF; Xie YS; Wang CQ
Eur J Prev Cardiol; 2016 Sep; 23(13):1421-8. PubMed ID: 26915580
[TBL] [Abstract][Full Text] [Related]
37. Aldosterone Antagonist Therapy and Mortality in Patients With ST-Segment Elevation Myocardial Infarction Without Heart Failure: A Systematic Review and Meta-analysis.
Dahal K; Hendrani A; Sharma SP; Singireddy S; Mina G; Reddy P; Dominic P; Modi K
JAMA Intern Med; 2018 Jul; 178(7):913-920. PubMed ID: 29799995
[TBL] [Abstract][Full Text] [Related]
38. High adherence to therapy and low cardiac mortality and morbidity in patients after acute coronary syndrome systematically managed by office-based cardiologists in Germany: 1-year outcomes of the ProAcor Study.
Goss F; Brachmann J; Hamm CW; Haerer W; Reifart N; Levenson B
Vasc Health Risk Manag; 2017; 13():127-137. PubMed ID: 28435280
[TBL] [Abstract][Full Text] [Related]
39. Incidence of atrial fibrillation detected by continuous rhythm monitoring after acute myocardial infarction in patients with preserved left ventricular ejection fraction: results of the ARREST study.
Romanov A; Martinek M; Pürerfellner H; Chen S; De Melis M; Grazhdankin I; Ponomarev D; Losik D; Strelnikov A; Shabanov V; Karaskov A; Pokushalov E
Europace; 2018 Feb; 20(2):263-270. PubMed ID: 28069838
[TBL] [Abstract][Full Text] [Related]
40. Frequency of Utilization of Beta Blockers in Patients With Heart Failure and Depression and Their Effect on Mortality.
Kim C; Duan L; Phan DQ; Lee MS
Am J Cardiol; 2019 Sep; 124(5):746-750. PubMed ID: 31277789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
